The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models. [PDF]
Bianchi G +11 more
europepmc +1 more source
Different cell surface oligomeric states of B7-1 and B7-2: Implications for signaling
S. Bhatia +3 more
semanticscholar +1 more source
The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. [PDF]
Agostini M, Traldi P, Hamdan M.
europepmc +1 more source
Expression of costimulatory molecules B7‐1 (CD80) and B7‐2 (CD86) on human hepatocellular carcinoma
T. Tatsumi +8 more
semanticscholar +1 more source
Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation. [PDF]
Nattress CB +18 more
europepmc +1 more source
TIME for Endometrial Cancer: Advancements and Challenges in Therapeutic Targets for the Endometrial Cancer Tumor Immune Microenvironment. [PDF]
Pruitt MR, Fabian KP, Lee JM, Hodge JW.
europepmc +1 more source
B7-2 (CD86) is essential for the development of IL-4-producing T cells.
A. Ranger +3 more
semanticscholar +1 more source
Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. [PDF]
Lutskovich DV +4 more
europepmc +1 more source
Dual-functional nanovesicles simultaneously inhibit stromal fibrosis and angiogenesis to suppress cholangiocarcinoma progression. [PDF]
Zhang L +14 more
europepmc +1 more source

